Century-old Vaccine Protects Type 1 Diabetics from Infectious Diseases

[skb]

Researchers from Massachusetts General Hospital conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine in people with type 1 diabetes during the COVID-19 pandemic
The objective of this research was to determine if the BCG vaccine protected type 1 diabetics from all infectious diseases, including COVID-19
In the MGH trial, BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall

Read More ...